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The efficacy of GABAergic synaptic inhibition is a principal factor in controlling neuronal activity. We demonstrate here that brain-
derived neurotrophic factor modulates the activity of GABAA receptors, the main sites of fast synaptic inhibition in the brain, within
minutes of application. Temporally, this comprised an early enhancement in the miniature IPSC amplitude, followed by a prolonged
depression. This modulation was concurrent with enhanced PKC-mediated phosphorylation, followed by protein phosphatase 2A
(PP2A)-mediated dephosphorylation of the GABAA receptor. Mechanistically, these events were facilitated by differential recruitment of
PKC, receptor for activated C-kinase, and PP2A to GABAA receptors, depending on the phosphorylation state of the receptor3-subunit.
Thus, transient formation of GABAA receptor signaling complexes has the potential to provide a basis for acute changes in receptor
function underlying GABAergic synaptic plasticity.
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Introduction
Neurotrophins modulate the activity of neuronal circuits by fa-
cilitating rapid changes in the efficacy of synaptic transmission
(Sanes and Lichtman, 2001; McAllister, 2001; Poo, 2001; Lu and
Gottschalk, 2000; Heerssen and Segal, 2002), elicited on their
binding, with high-affinity, to tyrosine kinase receptors (Trks),
and, with lower affinity, to the p75 receptor (Chao and Bothwell,
2002). Brain-derived neurotrophic factor (BDNF) has been pro-
posed to play a critical role in regulating fast synaptic inhibition
(Tanaka et al., 1997; Frerking et al., 1998; Boxall, 2000; Brunig et
al., 2001; Cheng and Yeh, 2003), as well as in the construction of
inhibitory synapses (Rico et al., 2002).
Fast synaptic inhibition in the adult brain is largely mediated
by GABA type A receptors (GABAARs), which are Cl
 permeable
heteropentameric ligand-gated ion channels. GABAARs can be
assembled from seven classes of homologous subunits: (1– 6),
(1– 4), (1– 4), , , , and  (Whiting et al., 1999), with the
most common subtypes in the brain being composed of -, -,
and 2-subunits (Whiting et al., 1999). For efficient inhibitory
neurotransmission, GABAARs are concentrated at synaptic sites
(Moss and Smart, 2001). At these specializations, GABAARs are
undergoing constitutive endocytosis, which may play a critical
role in shaping the response of the postsynaptic neuron to GABA.
GABAAR activity is also subject to regulation by direct phosphor-
ylation of the intracellular domains of the 1–3- and 2-subunits
by both serine/threonine and tyrosine kinases (Brandon et al.,
2002a,b). The -subunits play a key role in phospho-dependent
regulation, because they contain conserved residues (Ser409 in
1, Ser410 in 2, and Ser408/Ser409 in 3), which serve as sub-
strates for a number of kinases (Moss et al., 1992; Krishek et al.,
1994; Brandon et al., 2002a,b) and can mediate the bidirectional
modulation of receptor function by PKA (Moss et al., 1992a,b;
McDonald et al., 1998). However, the signaling pathways, which
regulate phosphorylation of native GABAA receptor in neurons
remain to be identified (Brandon et al., 2002a,b). Protein kinase
C (PKC) signaling pathways are likely to be of central impor-
tance, because it is evident that GABAARs directly associate with
both PKCII and the receptor for activated C-kinase (RACK-1)
in neurons (Brandon et al., 1999, 2000, 2002a,b). In addition,
PKA signaling pathways are also implicated as A-kinase anchor-
ing proteins (AKAPs) and can associate with some GABAAR sub-
types (Brandon et al., 2003).
To examine the mechanisms underlying the neurotrophin-
dependent modulation of GABAergic synaptic transmission, we
investigated the regulation of miniature GABAA receptor-
mediated miniature IPSCs (mIPSCs), GABAAR-subunit phos-
phorylation and cell surface stability in cultured cortical and hip-
pocampal neurons on exposure to BDNF. We report that BDNF
can elicit a parallel, biphasic temporal modulation of both
GABAergic synaptic currents and GABAAR-3 subunit phos-
phorylation by promoting the selective targeting of PKC,
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RACK-1, and protein phosphatase 2A (PP2A) to these receptors.
Concomitantly, BDNF increased the stability of 3-subunit-
containing GABAARs at the cell surface. Therefore, BDNF-
induced changes in GABAAR phosphorylation may provide a
dynamic mechanism for modulating the efficacy of fast synaptic
inhibition and, thereby, neuronal excitability in the brain.
Materials and Methods
Cell culture and transfection. Embryonic day 17 (E17) to E18 cerebral
cortical or hippocampal tissue was used to prepare primary neuronal
cultures as described previously (Goslin et al., 1998). Mammalian COS-7
cells were transfected by electroporation as described previously (Con-
nolly et al., 1999).
Metabolic labeling. Neuronal cultures were incubated in either
methionine-free DMEM containing 0.8 mCi [ 35S]methionine
(PerkinElmer Life Sciences, London, UK) for 12–14 hr, or in phosphate-
free DMEM containing 0.5 mCi [ 32P]orthophosphate (Amersham Bio-
sciences, Little Chalfont, UK) for 4 hr, followed by the addition of BDNF
(100 ng/ml, Alomone Labs, Jerusalem, Israel) for 10 min and lysis in
phosphate buffer (PB) containing the following: 10 mM NaPO4, pH 7.4,
5 mM EDTA, 5 mM EGTA, 100 mM NaCl, 10 mM Na pyrophosphate, 50
mM NaF, 100 M PMSF, and 10 g/ml of each of aprotinin, leupeptin,
and pepstatin, with 1% SDS (PB/SDS). SDS was neutralized by the addi-
tion of 5 vol of ice-cold PB with 2% NP-40 buffer (PB/NP-40), followed
by the incubation with 10 g of either nonspecific rat IgG, or GABAAR
3-specific, 2-specific, or -specific antibody (provided by Prof. W.
Sieghart, Brain Research Institute, Vienna, Austria) characterized previ-
ously (Tretter et al., 1997), and 100 l of protein A-Sepharose beads.
Immunoprecipitates were analyzed by SDS-PAGE and phosphorimager
spectrometry (Bio-Rad, Hemel Hempstead, UK).
Phosphorylation state-specific antibodies and immunoblot analysis. The
phosphorylation sites S408/S409-specific antibody (anti-P-3 antibody)
was produced using a peptide corresponding to residues 402– 412 of the
rat3-subunit, which was chemically phosphorylated at S408/S409 (Pro-
tein/DNA Technology Center, Rockefeller University, New York, NY) as
described previously (Czernik et al., 1991; Jovanovic et al., 1996), and
characterized using glutathione S-transferase (GST) fusion proteins en-
coding the intracellular transmembrane domain 3– 4 loop of GABAAR-
3-subunit phosphorylated in vitro by purified PKC (provided by Dr. A.
Nairn, Rockefeller University, New York, NY) as described previously
(McDonald and Moss, 1997). Forskolin, calphostin C, Rp-8Br-cAMP
(adenosine 3,5-cyclic monophosphorothioate, 8-bromo-2monobutyryl-
Rp-isomer), KN 93 (2[N-hydroxyethyl]N-(4 methoxybenzenesulfonyl)
amino-N-(4-chloroamamyl)-N-methylbenzylamine)), LY2460002, K252a,
and okadaic acid were purchased from Calbiochem (La Jolla, CA). To
measure changes in the phosphorylation state, quantitative immuno-
blotting with affinity-purified anti-P-3 antibody (1g/ml) or phospho-
independent PKC antibody (1:1000; Cell Signaling, Beverly, MA) was
performed using TBST buffer (50 mM Tris, pH 7.5, 200 mM NaCl, and
0.05% Tween 20) in the presence of 2 mg/ml BSA, followed by incubation
with [ 125I]-coupled anti-rabbit IgG (1 g/ml, Amersham Biosciences)
and quantified using phoshorimager spectrometry. Immunoblot analy-
sis using polyclonal GABAAR 3-specific antibody (1 g/ml), anti-pan
PKC antibody (1 g/ml; Upstate Biotechnology, Lake Placid, NY), and
polyclonal anti-PP2A antibody (1:500, Chemicon, Temecula, CA) was
performed under experimental conditions similar to those described
above, followed by incubation with [ 125I]-anti-rabbit polyclonal anti-
body. Immunoblotting with monoclonal anti-RACK-1 (0.5 g/ml, BD
Transduction Laboratories, Palo Alto, CA), and anti-PP2A antibodies
(0.1 g/ml, BD Transduction Laboratories) used alkaline phosphatase-
conjugated anti-mouse antibody (1 g/ml, Promega, Madison, WI) and
5-bromo-4-chlor-indolyl-phosphate/nitroblue-tetrazolium-chloride-
based colorimetric detection (Promega).
GST-protein pulldown assays and coimmunoprecipitation. GST pull-
down assays were performed as described previously (Brandon et al.,
1999). For coimmunoprecipitation analysis, cultured cortical neurons
were incubated in the absence or presence of BDNF (100 ng/ml) and
lysed under nondenaturing conditions (Brandon et al., 1999). Cell lysates
were incubated with 10 g of either nonspecific rat IgG, or GABAAR
3-specific antibody, followed by protein A-Sepharose. Immunoprecipi-
tates were analyzed by SDS-PAGE and immunoblotted with pan-PKC,
RACK-1, and PP2A antibodies as described above.
Whole-cell electrophysiology. mIPSCs were recorded from cultured
hippocampal neurons [14 –21 d in vitro (DIV)] using the whole-cell
patch-clamp technique in conjunction with a patch-clamp amplifier.
Thin-walled borosilicate glass patch electrodes (resistance, 1–5 M)
were filled with a solution containing the following (in mM): 140 KCl or
CsCl, 2 MgCl2, 1 CaCl2, 10 HEPES, 11 EGTA, and 2 adenosine triphos-
phate, pH 7.2. Neurons were continuously superfused with a Krebs’ so-
lution containing the following (in mM): 140 NaCl, 4.7 KCl, 1.2 MgCl2,
2.5 CaCl2, 10 HEPES, and 11 glucose, pH 7.4 at 31°C. The neurons were
voltage-clamped at70 mV with all membrane currents filtered at 5 kHz
(3 dB, sixth-pole Bessel, 36 dB/octave) before being digitized on-line
with a Digidata 1320A (Axon Instruments, Foster City, CA) and analyzed
off-line using either Strathclyde electrophysiology software (WinWCP
version 3.2.7, J. R. Dempster, Strathclyde University, Glasgow, UK) or
Mini Analysis (version 5.6.7, Synaptosoft, Decatur, GA). Drugs and
Krebs’ solutions were applied rapidly (30 msec solution exchange rate)
using a modified U-tube. Throughout all recordings, the external solu-
tion contained both 10 M CNQX and 200 nM TTX (Tocris Cookson,
Bristol, UK) to block glutamatergic non-NMDA-receptor-mediated EP-
SCs and voltage-dependent Na channel activity, respectively. BDNF
was either bath-applied or pressure-pulse-applied to neurons from a
nearby blunt patch pipette (resistance1M) at 1 Hz, 200 msec, 50 kPa,
or for 30 sec, every 2 min, for the duration indicated. Statistical analyses
involved either Student’s paired t test or a one-way ANOVA with a Bon-
ferroni post-test; p 0.05 was considered significant.
Immunocytochemistry, cell-surface ELISAs, and biotinylation assays.
Hippocampal neurons (14 DIV) were incubated in the absence or pres-
ence of BDNF (100 ng/ml) for 30 min, fixed using 4% paraformaldehyde,
and incubated with a combination of either anti-TrkB monoclonal anti-
body (BD Transduction Laboratories)/anti-GABAAR-3 polyclonal an-
tibody, or anti-GABAAR-2/3 monoclonal (bd17) antibody (Chemicon)/
anti-vesicular inhibitory amino acid transporter antibody (provided by
Dr. A. Triller, Centre National de la Recherche Scientifique, Paris,
France), followed by incubation with FITC/Texas red-conjugated sec-
ondary antibodies and analysis using confocal microscopy (Bio-Rad).
Hippocampal neurons (14 DIV) and cortical neurons (8 DIV) were in-
cubated in the absence or presence of BDNF (100 ng/ml) or insulin (0.5
M; Sigma, St. Louis, MO) for 10, 20, or 30 min, fixed using 4% parafor-
maldehyde and cell-surface ELISAs were performed as described previ-
ously (Noel et al., 1999), using 5 g/ml of bd17 (Chemicon) against the
GABAA receptor 2 and 3 subunits. Biotinylation assays were per-
formed with cultured neurons as described previously (Mammen et al.,
1997) using 1 mg/ml sulfo-biotin-N-hydroxysuccinimide ester (NHS)-
biotin (Pierce) at 4°C, after incubation in the presence or absence of
BDNF (100 ng/ml). Biotinylated cell-surface proteins were precipitated
using UltraLink Immobilized NeutrAvidin Biotin binding protein
(Pierce, Rockford, IL) and resolved by SDS-PAGE. The amount of bio-
tinylated 3-subunit and GluR1-subunit of AMPA receptors were deter-
mined by immunoblotting with 3-specific and GluR1-specific anti-
bodies (Chemicon), followed by [ 125I]-coupled anti-rabbit IgG, and
subsequent phosphorimager analysis.
Results
Biphasic temporal modulation of GABAergic mIPSCs
by BDNF
The effects of BDNF on synaptic GABAA receptors were exam-
ined using dissociated hippocampal pyramidal neurons main-
tained in culture (14 DIV) by measuring both amplitudes and
frequencies of mIPSCs. Pulsed application (i.e., 30 sec duration,
every 2 min for the time indicated in the plots, see Materials and
Methods), or bath application of BDNF (200 ng/ml) induced a
rapid, but transient potentiation (122 4.4% of control; n 11
of 21) of the mean mIPSC amplitude over the course of 10 min in
a large subset of neurons (Fig. 1a, early BDNF, 1c, supplemental
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Fig. 1). This potentiation eventually re-
turned to the control amplitude level (Fig.
1a, control, 1c, supplemental Fig. 1) and
after continued exposure to BDNF became
a long-lasting depression that attained a
steady state after 20 –25 min (Fig. 1a, late
BDNF, 1c, supplemental Fig. 1). Cumula-
tive amplitude plots reflected a significant
potentiation followed by an inhibition of
peak mIPSC amplitudes in the early and
late phases of BDNF treatment (Fig. 1b). In
two other subsets of neurons (10 of 21
cells), application of BDNF caused either
no discernible effect or a gradual run-
down, the later phenomenon being seen in
2% of the total population (data not
shown). It is evident that BDNF produced
heterogeneous effects on mIPSC ampli-
tudes; this is likely to be caused by the ex-
pression of TrkB receptors in 70% of
hippocampal pyramidal neurons in cul-
ture (Fig. 1e). In addition, hippocampal
neurons express a broad range of GABAA
receptors including the: 1–5-, 1–3-, 2-,
and -subunits as defined by in situ hy-
bridization and immunohistochemistry
(Laurie et al., 1992; Pirker et al., 2000), giv-
ing the basis for extensive structural heter-
ogeneity of the GABAA receptor. Given
that functional effects of phosphorylation
are dependent on the subunit composition
of GABAA receptor (McDonald et al., 1998;
Brandon et al., 2002a,b), the expression of
differing receptor assemblies in individual
neurons could also contribute to the diverse
effects of BDNF treatment. In addition to the
postsynaptic amplitude effects of BDNF in
hippocampal neurons, a presynaptic element was manifested as an
increase in the frequency of mIPSCs, which attained a plateau after
15–20 min (Fig. 1d). The specificity of the signaling pathway acti-
vated by BDNF was revealed by using the TrkB receptor antagonist,
K252a (200 nM). This antagonist blocked all of the effects of BDNF
that were observed on the hippocampal synaptic GABAA receptors
with the mIPSC frequency (data not shown) and amplitude indis-
tinguishable from the controls (200 nM K252a) (Fig. 1c).
To analyze whether BDNF (200 ng/ml) was affecting the ki-
netics of the mIPSCs, the decay and rise times of epochs of spon-
taneous activity were studied. For mIPSCs recorded from hip-
pocampal neurons (3 min duration), the rate of rise and decay for
individual mIPSCs was fitted by single-exponential functions for
cells superfused with control Krebs’ solution and after the appli-
cation of BDNF. This yielded the following values for the rise time
(10 –90%) and decay time of mIPSCs, respectively: control Krebs’
solution, 1.31  0.11 and 14.4  1.3 msec (n  10); BDNF,
during the peak amplitude potentiation of mIPSCs, 1.91  1.2
and 17.02 4.7 msec (n 5);BDNF, during the depression of
mIPSC amplitudes, 1.83  0.9 and 12.16  0.53 msec (n  4).
These differences were not significant ( p	 0.05).
Phosphorylation state of the GABAAR is regulated by BDNF
Because BDNF can cause the downstream activation of protein
kinases, we sought to determine whether any changes in the
GABAAR phosphorylation state occurred concurrently with the
acute modulation of GABAergic mIPSCs. This was achieved by
immunoprecipitation, using selective antibodies for2-,3-, and
2-subunits, which represent the main phosphorylated subunits
within the majority of GABAAR subtypes (Moss et al., 1992a,b;
McDonald and Moss, 1994; Brandon et al., 2002a,b), from ex-
tracts of [ 32P]orthophosphate-labeled cortical neurons. Applica-
tion of BDNF (100 ng/ml) resulted in a rapid increase in the
phosphorylation state of the 3-subunit, whereas phosphoryla-
tion of 2- and 2-subunits was not detected (Fig. 2a). To con-
firm the presence of the 2- and 2-subunits in immunoprecipi-
tated material, we performed metabolic labeling of cortical
neurons with [ 35S] methionine. This approach revealed that both
2- and 2-subunits were immunoprecipitated by their respec-
tive antibodies from cortical neuronal lysates, in addition to high
levels of immunoprecipitated 3-subunit (Fig. 2b).
To further investigate GABAAR–3-subunit-specific phos-
phorylation in response to BDNF, we raised and purified a phos-
phorylation state-specific antibody (anti-P-3 Ab) directed to-
ward the major phosphorylated residues, Ser408 and Ser409,
phosphorylation of which has been shown previously to enhance
GABAAR channel activity in heterologous systems (Moss et al.,
1992a,b; McDonald and Moss, 1997; McDonald et al., 1998). This
anti-P-3 antibody specifically recognized the intracellular do-
main of the 3-subunit expressed as a GST fusion protein (GST-
3) when phosphorylated in vitro by PKC (Fig. 2c, lanes 3 and 4),
with no detectable immunoreactivity against mock phosphory-
Figure 1. TrkB receptor activation by BDNF modulates synaptic GABAA receptor function in hippocampal neurons. a, Peak
amplitude histogram plots taken from 1 min epochs of mIPSCs recorded from a hippocampal neuron (14 DIV) in the absence
(control) and subsequent presence of BDNF (200 ng/ml) after 5 min (Early BDNF) and 30 min (Late BDNF) exposure. b, Cumulative
probability plot for the mIPSC peak amplitudes, which demonstrates the significance of the current potentiation in the presence
of BDNF (200 ng/ml) for 5 min (early BDNF), and the current inhibition at the later time point (30 min, late BDNF) relative to the
untreated control. Data are taken from a single cell presented in a. c, Time-stability relationship for mIPSC amplitudes in control
Krebs’ solution (filled circles) and after the application of either 200 ng/ml BDNF (squares) or 200 nM K252a (open circles). The BDNF
was applied for the duration indicated by the solid line (see Materials and Methods) and K252a was present in the Krebs’ solution
before the start of the recordings. The mIPSC amplitudes were normalized to the mean mIPSC amplitudes in control Krebs’ solution
(1). All points represent means SE from n 11 cells. *p 0.05. The bar represents the period of BDNF application. d, mIPSC
frequency sampled from neurons in control Krebs’ solution (black column) and during the application of 200 ng/ml BDNF (gray
columns). The mIPSC frequencies were measured during 1 min epochs at the indicated recording times after whole-cell formation
and normalized to the control values in individual cells (1). All bars represent means SE, n 6. *p 0.05 level. The horizontal
line represents the time of BDNF application. e, Average number of TrkB neurons in comparison with the total number of
hippocampal neurons (14 DIV) per visual field.
524 • J. Neurosci., January 14, 2004 • 24(2):522–530 Jovanovic et al. • GABAA Receptor Modulation
lated GST-3 (Fig. 2c, lanes 1 and 2). Immunoblotting with anti-
P-3 antibody (Fig. 2d, top) revealed a specific band of58 kDa
present only in lysates from COS-7 cells transfected with the
3-subunit under control conditions, which was strongly en-
hanced by forskolin, an activator of PKA (Fig. 2d, top, lanes 3,
andforskolin, respectively). The total level of transfected wt3,
as detected by a 3-subunit-specific, phosphorylation state-
independent antibody, remained constant (Fig. 2d, bottom, lane
3). The anti-P-3 immunoreactive band was absent in lysates
from mock-transfected controls, cells transfected with 1- and
2-subunits only, or in combination with 3-subunit mutants of
either the single-phospho site S408A or S409A, or the di-phospho
site S408A/S409A (Fig. 2d, lanes 1, 2, 4, 5, and 6, respectively).
The expression levels of these phospho-site mutants were de-
tected using the 3-subunit-specific antibody (Fig. 2d, bottom).
Some weak, nonspecific bands of higher molecular weight were
detected with the anti-P-3 antibody in COS-7 cell lysates, but
these bands did not represent GABAAR3-specific immunoreac-
tivity because they were also present in mock-transfected cells.
Using anti-P-3 antibody, we detected a single band of58 kDa
in SDS extracts from cortical neurons, identical in molecular
mass to recombinant 3-subunit (Fig. 2e,  lanes), which was
enhanced by the application of BDNF (100 ng/m) (Fig. 2e, 
lanes). The immunodetection of the 58
kDa band by the anti-P-3 antibody was
prevented by a synthetic peptide phos-
phorylated at the equivalent S408/S409
residues. However, the presence of a pep-
tide phosphorylated at the residue equiva-
lent to S408 alone, or a peptide phosphor-
ylated at S409 alone, or a dephospho-
S408/S409 peptide (Fig. 2e) showed little
or no interference with the immunodetec-
tion of the phosphorylated 3-subunit.
Together, these results demonstrated that
anti-P-3 antibody specifically recognized
the phosphorylated form of the neuronal
GABAAR-3 subunit.
Biphasic temporal modulation of
GABAAR-3 phosphorylation by BDNF
By immunoblotting cortical neuronal lysates
with the anti-P-3 antibody, we detected a
rapid and transient BDNF-dependent in-
crease in the phosphorylation of GABAAR-
3-subunit (412 79% at 5 min of incuba-
tion with BDNF), followed by a decrease to
50  13% of the untreated control level in
the presence of BDNF for 30 min (Fig. 3a,
top). The total amount of GABAAR-3-
subunit remained stable (Fig. 3a, bottom).
In hippocampal neurons, the application of
BDNF (100 ng/ml) produced a similar mod-
ulation of GABAAR-3-subunit phosphory-
lation, reaching an enhanced level of 131
2% within 5 min, followed by a decrease to
the basal level of phosphorylation within 10
min of incubation and a further decrease to
43 2% of the untreated control level by 20
min of incubation (Fig. 3b). The total
amount of GABAAR-3 remained stable in
the presence of BDNF (data not shown).
To determine whether similar changes
in both the amplitude of GABAergic mIPSCs and GABAAR-3-
subunit phosphorylation state were accompanied by changes in
cell-surface levels of GABAAR, we performed cell-surface ELISAs,
using an extracellular 2/3-subunit epitope-specific monoclo-
nal antibody, bd17. Incubation of BDNF with cortical (Fig. 3c) or
hippocampal (Fig. 3d) neurons, resulted in an increase in the
surface stability of 2/3-containing GABAARs within 10 min
(Fig. 3d). The increased cell-surface expression of GABAARs then
remained constant over an additional 30 min period, reaching
levels of 128 7% ( p 0.05; n 4) (Fig. 3c) and 117 6% of
control ( p  0.05; n  4) (Fig. 3d) in both the cortical and
hippocampal neurons, respectively. The BDNF-dependent in-
crease in levels of 2/3-containing-GABAARs at the cell surface
was similar to the increase detected in response to insulin (Fig.
3d) (Wan et al., 1997). To measure changes in the subpopulation
of GABAARs containing 3-subunits specifically, in response to
BDNF, we performed biotinylation assays followed by quantita-
tive immunoblotting. The amount of biotin-labeled GABAAR-3
in cortical neurons was increased (164  16% of control; p 
0.05; n  4) by BDNF, which could be prevented by the TrkB
receptor inhibitor, K252a (200 nM) (Fig. 3e). The same treatment
resulted in no significant change in the cell-surface expression of
GluR1-containing AMPA receptors (109 14% of control; n
Figure 2. GABAAR 3-subunit-specific phosphorylation in response to BDNF. a, b, Immunoprecipitation with control rabbit
IgG, or antibodies specific for the 3-, 2-, or 2-subunit of GABAARs was performed using lysates from either
[ 32P]orthophosphate-labeled cultured cortical neurons incubated in the absence () or presence () of BDNF (100 ng/ml) for 10
min ( a), or [ 35S]methionine-labeled cultured cortical neurons ( b). Arrows indicate migration of individual GABAAR subunits. c,
Anti-phospho-3 antibody binds specifically to P-GST3 (lane 3, 100 ng; lane 4, 200 ng) with no cross-reactivity to mock P-GST3
(lane 1, 100 ng; lane 2, 200 ng). d, Equal protein amounts of SDS lysates from mock-transfected COS-7 cells (lane 1), cells
transfected with either GABAAR1- and 2s-subunits only (lane 2), or in combination with GABAAR3 wild-type (wt) subunit
(lane 3), or3 mutants containing S408A mutation (lane 4), S409A mutation (lane 5), or S408/9A mutation (lane 6), which were
incubated in the absence (), or presence () of forskolin (20M) for 20 min, were analyzed by immunoblotting with anti-P-3
antibody (top), or 3-specific antibody (bottom). Arrows indicate the migration of P-3 antibody-reactive band detected in
lysates containing wt 3-subunit, which was enhanced by forskolin (P-3 , top) or migration of wt or mutant 3-subunits
detected by3-specific antibody (3 , bottom). e, Immunoblot analysis using anti-P-3 antibody alone (lane 1) or using the same
concentration of anti-P-3 antibody preincubated with either synthetic dephospho-S408/409 peptide (lane 2), or chemically
phosphorylated phospho-S408/409 (lane 3), phospho-S408 (lane 4), or phospho-S409 peptide (lane 5) of SDS lysates obtained
from cultured cortical neurons incubated in the absence () or presence () of BDNF (100 ng/ml) for 5 min. All peptides were
incubated at 500-fold molar excess. Arrow indicates a migration of a58 kDa band corresponding to phosphorylated neuronal
GABAAR-3-subunit.
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4). The amount of biotin-labeled GABAAR-3 in hippocampal neu-
rons was also increased (114 7% of control; p 0.05; n 4) by
BDNF (Fig. 3f), whereas the level of GluR1-containing AMPA re-
ceptors remained unchanged (98 6% of control; n 4).
PKC-mediated GABAAR phosphorylation and potentiation
of mIPSCs
To determine whether the activity of TrkB tyrosine kinase was
required for the BDNF-induced phosphorylation of GABAAR-
3-subunits, as observed for BDNF-induced changes in mIPSC
amplitude, we incubated cortical neurons in the presence of K252a
(200 nM), before the addition of BDNF (100 ng/ml) for 10 min.
Immunoblotting with anti-P-3 antibody demonstrated that
GABAAR-3 phosphorylation in BDNF-treated samples was
completely inhibited by K252a (Fig. 4a). However, TrkB receptors
and GABAAR-3-subunits showed almost no overlap in subcel-
lular localization in hippocampal (Fig. 4b) and cortical neurons
(data not shown) as revealed by double-labeling and immunoflu-
orescence analysis, which suggested that a diffusible signal is
likely to mediate the phosphorylation of GABAAR in response to
TrkB activation.
To identify which signaling pathways were activated down-
stream of TrkB to modulate the phosphorylation of GABAAR-3,
we incubated cultured neurons in the absence or presence of the
following protein kinase inhibitors (Fig. 4c): PKC-specific inhib-
itor, calphostin C (0.2 M, lane 3), PKA-specific inhibitor, Rp-8-
Br-cAMP (200 M, lane 4), Ca 2/calmodulin (CaM) kinase-
specific inhibitor, KN-93 (2 M, lane 5), and phosphatidyl-3
(PI-3) kinase-specific inhibitor, LY249002 (2 M, lane 6). All
inhibitors were included before the addition of BDNF for 10 min
(100 ng/ml). Immunoblot analyses with the anti-P-3 antibody
demonstrated that the BDNF-dependent increase in phosphory-
lation of GABAAR-3 (398  46%) (Fig. 4c, lane 2) was signifi-
cantly inhibited by calphostin C (188  21%; p  0.05; n  7)
and LY249002 (194  31%; p  0.05; n  5). Moreover, the
addition of both inhibitors (Fig. 4c, lane 7) led to an almost
complete inhibition of BDNF-dependent phosphorylation of
3-subunits (114  5%), indicating that both PKC and PI-3
kinase activities are critical in mediating the effects of BDNF.
The total amount of GABAAR-3 remained stable in the pres-
ence of all of the protein kinase inhibitors tested, as detected
by immunoblotting with a 3-subunit specific antibody (data
not shown).
We also investigated whether the activity of LY294002-
sensitive PI-3-kinase signaling pathway played any role in deter-
mining BDNF-dependent activation of PKC (Dutil et al., 1998; Le
Good et al., 1998), using a phosphorylation-state-specific pan-
PKC antibody (Fig. 4d) (Keranen et al., 1995). In the presence of
LY249002 (2 M), the BDNF-induced phosphorylation of PKC
(185 18%) (Fig. 4d, lane 2) was significantly inhibited to 145
10% ( p  0.05; n  4) (Fig. 4d, lane 3), indicating synergistic
activation of PKC by both PLC-dependent and PI-3 kinase/
PDK-1-dependent pathways in response to BDNF. Similar inhi-
bition of BDNF-dependent activation of PKC was observed in the
presence of K252a, using the phosphorylation-state-specific pan-
PKC antibody (Fig. 4e, lane 3).
We next tested whether the PKC activity phosphorylating
GABAAR-3 was sensitive to changes in intracellular Ca
2 con-
centration by incubating cortical neurons in the absence or pres-
ence of EGTA (1 mM), or BAPTA-AM (25 M), added before
BDNF (100 ng/ml) for 10 min. Immunoblotting with anti-P-3
antibody demonstrated that the enhancement of GABAAR-3
phosphorylation by BDNF (202  14%) (Fig. 4f, lane 2), al-
though insensitive to a decrease in extracellular concentrations of
Ca 2 (192 19%) (Fig. 4f, lane 3), was completely inhibited by
the removal of intracellular Ca 2 by BAPTA-AM (95 24%; p
0.05; n 4) (Fig. 4f, lane 4).
The temporal correlation between the changes in GABAAR
phosphorylation and mIPSC amplitudes in response to BDNF
suggested that these two phenomena may be linked by a common
signaling pathway downstream of TrkB. To investigate this, we
used whole-cell voltage clamp to record mIPSCs from cultured
hippocampal neurons incubated in the presence of calphostin C
(200 nM) before the addition of BDNF (200 ng/ml). Calphostin C
significantly inhibited both the initial enhancement and also the
later inhibition of mIPSC amplitudes induced by the application
of 200 ng/ml BDNF alone (Fig. 4g). These results indicated that
both the potentiation and inhibition of GABAA-receptor-
mediated synaptic currents rely on elements within the same
signal transduction pathway regulated by BDNF, and may re-
quire the phosphorylation of GABAAR-3-subunits by PKC.
PP2A-mediated GABAAR dephosphorylation and inhibition
of mIPSCs
To characterize phosphatase activity mediating dephosphoryla-
tion of GABAAR-3-subunits by BDNF during the later stages of
incubation, cortical neurons were treated with okadaic acid (0.5
Figure 3. BDNF-dependent changes in phosphorylation and cell-surface expression of neu-
ronal 3-containing GABAARs. a, b, Time course of BDNF-activated phosphorylation/dephos-
phorylation of neuronal GABAAR-3 in cortical neurons (8 DIV, a) or hippocampal neurons (14
DIV, b) incubated in the presence of BDNF (100 ng/ml) for the indicated times and analyzed by
immunoblotting with anti-P-3 antibody (top), or3-subunit-specific antibody (bottom). The
panels below the histograms show individual examples of immunoblots. *Significantly differ-
ent from control ( p 0.05; n 5; Student’s paired t test). c, d, BDNF enhances the cell surface
levels of2 /3-subunits in cortical neurons ( c) or hippocampal neurons ( d) incubated in the
absence or presence of BDNF 100 ng/ml or insulin 0.5M for the indicated times. Cell-surface
ELISAs were performed using monoclonal antibody bd17 specific for the GABAA receptor 2-
and3-subunits (5g/ml), and results are presented as the percentage of untreated control at
each of the indicated times. *Significantly different from control ( p 0.05; n 4; Student’s
paired t test). e, f, BDNF enhances the cell-surface levels of3-subunit in cortical neurons ( e) or
hippocampal neurons ( f) incubated alone (1), with 100 ng/ml BDNF (2), or with 100 ng/ml
BDNF K252 (3), followed by sulfo-NHS-biotin labeling of cell-surface proteins and immuno-
precipitation using NeutrAvidin-Sepharose. The amount of biotin-labeled3-subunit with3-
specific antibody and expressed as percentage of untreated controls. *p 0.05 (n 3).
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M, OA), a broad-spectrum inhibitor of
protein phosphatase 1 (PP1) and protein
phosphatase 2A (PP2A); or cyclosporin A
(1 M, CsA), a specific inhibitor of CaM-
dependent protein phosphatase 2B
(PP2B)/calcineurin, (Price and Mumby,
1999; Fernandez et al., 2002). The inhibi-
tors were applied before the incubation
with BDNF (100 ng/ml) for 5, 10, and 20
min. Immunoblotting with anti-P-3 an-
tibody revealed that the basal phosphory-
lation of 3-subunits was significantly in-
creased only in the presence of okadaic
acid (Fig. 5a). The concentration-
dependent increase in basal phosphoryla-
tion of GABAAR-3 by okadaic acid
(0.05–2 M) produced an IC50 for phos-
phatase inhibition of 70  23 nM (n  4)
(Fig. 5b), indicating that PP2A, rather than
PP1, was likely to be involved with the
phosphorylation state of the GABAAR-3
(Nishi et al., 2002). The inhibition of PP2A
by okadaic acid resulted in a hyperphos-
phorylated state for GABAAR-3-subunits
under basal conditions (1187  253%)
(Fig. 5c, lane 4), which appeared to limit
their sensitivity to modulation by BDNF at
early time points (Fig. 5c, BDNF 10 min:
390 51% of basal phosphorylation, lane 2;
OA/BDNF 10 min: 1525  197% of basal
phosphorylation, lane 5). Importantly, the
inhibition of PP2A by okadaic acid com-
pletely abrogated the BDNF-dependent
dephosphorylation of GABAAR-3 observed
at the later incubation time points (Fig. 5c,
BDNF 30 min: 55 6%, lane 3; OA/BDNF
30 min: 1638 210%, lane 6).
To further correlate changes in the
phosphorylation state of GABAAR-3-
subunits with changes in mIPSC ampli-
tudes, we performed whole-cell recordings
of mIPSCs from cultured hippocampal
neurons incubated in the presence of oka-
daic acid (200 nM) before the addition of
BDNF (200 ng/ml). Under these condi-
tions, only a moderate and transient in-
crease in mIPSC amplitudes at early time
points was observed (Fig. 5d, 111 5% at
10 min). Importantly, in the presence of
okadaic acid, the depression of the mean
mIPSC amplitude below control levels,
which was observed in the presence of
BDNF alone, was completely abolished.
These results indicated that PP2A activity
is critical for the onset of depression in the
mIPSC amplitudes at least in part by me-
diating the rapid dephosphorylation of3-
subunit-containing GABAARs.
Differential recruitment of PKC, RACK-
1, and PP2A to GABAARs
We subsequently determined whether the
biphasic modulation of the phosphoryla-
Figure 4. PKC activity mediates both BDNF-dependent GABAAR phosphorylation and potentiation of mIPSCs. a, K252a-
inhibited BDNF-induced phosphorylation of GABAAR-3. Cortical neurons were incubated alone (1), with 200 n
 K252a (2), with
100 ng/ml BDNF (3), or with 200 n
 K252a 100 ng/ml BDNF (4) for 10 min and then lysed. Immunoblotting with anti-P-3
antibody was performed using equal protein amounts of SDS lysates. *p 0.05 (n 3). b, Subcellular localization of TrkB (red)
and GABAAR-3-subunit (green) in hippocampal neurons (14 DIV). Scale bar, 10m. c, Potentiation of GABAAR-3 phosphory-
lation by BDNF is dependent on PKC and PI-3 kinase activities. Cortical neurons were incubated alone (1), or with 0.2M calphostin
C (3); 200 M Rp-8Br-cAMP (4); 2 M KN-93 (5); 2 M LY 294002 (6); or both calphostin C and LY 294002 (lane 7) for 10 min,
followed by the addition of BDNF (100 ng/ml), and incubated for an additional 10 min. Lane 2 represents samples treated with
BDNF alone. Immunoblotting with anti-P-3 antibody was then performed as in a. The panels below the histogram show
individual examples of immunoblots. BDNF-induced 3-subunit phosphorylation was significantly inhibited in the presence of
calphostin C, LY294002, or both inhibitors. *p 0.05 (n 4 –7). d, e, BDNF-enhanced phosphorylation of PKC on Ser660 was
dependent on PI-3 kinase activity ( d) or TrkB kinase activity ( e) in cortical neurons incubated in the absence (1) or presence of
either 2M LY294002 (d, lane 3) or 200 nM K252a (e, lane 3) for 10 –15 min, followed by the addition of BDNF (100 ng/ml) and
additional incubation for 10 min (lane 2). Equal protein amounts were subjected to immunoblotting with pan-P-PKC antibody.
*p 0.05) (n 4). The panel below the histogram shows a representative immunoblot of the higher molecular mass band
migrating at 97 and the lower band migrating above 66 kDa. f, Potentiation of GABAAR-3 phosphorylation by BDNF was
abrogated by BAPTA-AM in cortical neurons. Cells were incubated in the absence (lanes 1 and 2) or presence of either 1M EGTA
(lane 3) or 25 M BAPTA-AM (lane 4) for 5–10 min, followed by the addition of BDNF (100 ng/ml) to samples in lanes 2– 4.
Incubation was then extended for an additional 10 min. Immunoblotting with anti-P-3 antibody was performed using equal
protein amounts of SDS lysates. *p 0.05 (n 4). The panel below the histogram shows a representative immunoblot. g,
Time-stability relationships for hippocampal mIPSC amplitudes in control Krebs’ solution (filled circles) and after the application
of either 200 ng/ml BDNF (squares) or 200 nM calphostin C (triangles). BDNF was applied for the duration indicated by the solid line
(see Materials and Methods), and calphostin C was applied to the Krebs’ solution before the start of the recordings. The mIPSC
amplitudes were normalized to the mean mIPSC amplitudes in control Krebs’ solution. All points are means SE from n9 cells.
Data for the control and the BDNF treatments were obtained from Figure 1a.
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tion states of 3-subunit-containing GABAARs could be regu-
lated by the temporal characteristics of their direct association
with PKC and PP2A. Cortical neurons were incubated in the
absence or presence of BDNF (100 ng/ml) for 10 or 30 min, and
immunoprecipitation was performed using either nonspecific
rabbit IgG or a GABAAR 3-subunit-specific antibody. A weak
immunoreactive band with a molecular weight similar to that of
PKC was detected in 3 immunoprecipitates from control sam-
ples (Fig. 6a, top, input), but was absent in immunoprecipitates
obtained using nonspecific rabbit IgG. The same immunoreac-
tive band was significantly increased during the first 10 min of
incubation with BDNF and then diminished to undetectable lev-
els by 30 min of incubation with BDNF (Fig. 6a, top). Similar
experimental approaches detected the transient recruitment of
RACK-1 to the GABAAR-3-subunit in the presence of BDNF
(Fig. 6a, middle). In addition to PKC and RACK-1, the presence
of the catalytic subunit of PP2A (PP2Ac) was also detected in
3-subunit immunoprecipitates from control and BDNF-treated
samples (Fig. 6a, bottom). However, a significant amount of
PP2Ac remained associated with 3-containing GABAAR at later
incubation time points with BDNF, possibly mediating the ob-
served rapid dephosphorylation of GABAAR-3.
It is conceivable that the transient association of PKC with the
GABAAR-3-subunit in response to BDNF may be a consequence
of phosphorylation of S408/S409 by this kinase. Although the
direct binding of PKC to the sequence overlapping S408/S409
(residues 405– 415) in3-subunits in vitro is independent of these
two residues (Brandon et al., 1999), it is unclear whether phos-
phorylation affected PKC dissociation. Samples containing equal
amounts of phosphorylated GST-3 (P-GST3, 0.8 mol phos-
phate/mol protein, phosphorylated in vitro by purified PKA), or
unphosphorylated GST-3 (mock P-GST3), or GST alone, were
incubated with rat brain extracts and analyzed for the presence of
PKC by quantitative immunoblotting with a pan-PKC antibody
(Fig. 6b). The extent of PKC binding to the intracellular loop of
3 was significantly decreased to 37  12% of control by the
phosphorylation of S408/S409. In contrast, the association of
PP2A with GABAAR-3-subunits was potentiated to 146 15%
of control (Fig. 6c).
Together, our results demonstrate that BDNF-dependent
rapid enhancement of GABAA receptor activity, followed by a
long-lasting depression, proceeds concurrently with a BDNF-
dependent enhancement in 3-subunit phosphorylation at sites
S408/S409, followed by dephosphorylation of these sites at later
stages. The time course and extent of GABAAR phosphorylation
were determined, at least in part, by the dynamics of phospho-
dependent recruitment of PKC, RACK-1, and PP2A to GABAA
receptors in response to BDNF. This situation represents a novel
Figure 5. PP2A activity mediates BDNF-dependent GABAAR dephosphorylation and inhibi-
tion of mIPSCs. a, Time course of BDNF-activated phosphorylation/dephosphorylation of
GABAAR-3 in the presence of phosphatase inhibitors. Cortical neurons were incubated in the
absence or presence of either okadaic acid (0.5M, OA) or cyclosporin A (1M, CsA) for 10 min,
followed by the addition of BDNF (100 ng/ml) and incubation for an additional 5, 10, or 20 min.
Immunoblotting with anti-P-3 antibody was performed using equal protein amounts of SDS
lysates. The immunoblot is representative of three independent experiments. b, Concentration-
dependent increase in phosphorylation of GABAAR-3 in cortical neurons incubated with
increasing concentrations of okadaic acid (0.05–2 M) for 30 min. Immunoblotting with
anti-P-3 antibody was performed using equal total protein amounts. c, Occlusion of
BDNF-dependent phosphorylation of GABAAR-3 in cortical neurons. Neurons were incu-
bated in the absence (lanes 1–3) or presence (lanes 4 – 6) of 0.1 M okadaic acid for 15
min, followed by the addition of 100 ng/ml BDNF for 10 min (lanes 2 and 5) or 30 min
(lanes 3 and 6). Immunoblotting with anti-P-3 antibody was performed using equal
protein amounts of SDS lysates. Data represent means  SE from three independent
experiments. *p  0.05 (n  3). d, Time-stability relationship for hippocampal mIPSC
amplitudes recorded in the presence of 0.1 M okadaic acid (open circles) and shown
relative to experiments performed in the presence of control Krebs’ solution (filled circles),
BDNF (squares; 200 ng/ml), or calphostin C (triangles; 200 nM). Okadaic acid was applied
either directly to the culture medium before recording or it was directly loaded into the
patch pipette. mIPSC amplitudes were normalized to control data in Krebs’ solution. All
points are the means SE from n 7 cells. Data for control, BDNF, and calphostin C were
obtained from Figure 4e.
Figure 6. Transient phosphorylation-dependent recruitment of PKC, RACK-1, and PP2Ac to
GABAAR-3 in response to BDNF. a, Time course of BDNF-induced association of GABAAR-3
with PKC, RACK-1, and PP2A. Cortical neurons were incubated in the absence or presence of
BDNF (100 ng/ml) for 10 or 30 min. Cells were lysed under nondenaturing conditions, and
immunoprecipitation was performed using nonspecific rabbit IgG (10g, Con), or3-specific
antibody (0 10, and 30; 10g3 antibody). Immunoprecipitates were analyzed by immu-
noblotting with pan PKC-specific antibody (top), RACK-1-specific antibody (middle), or anti-
body specific for the catalytic subunit of PP2A (bottom). Lane “In” represents 10% of the input
used in each experiment. Immunoblots are representative of three independent experiments.
b, Phosphorylation of Ser408/409 residues in the 3-subunit inhibits binding of PKC in vitro.
Samples containing 20g of either mock P-GST3 (lane 1), P-GST3 (lane 2), or GST (lane 3)
alone were incubated with 5 mg of rat brain homogenate and analyzed by immunoblotting
with pan-PKC specific antibody. The input lane contained 2% of the material used in GST pull-
down incubations. The binding of PKC to the intracellular loop of the 3-subunit was signifi-
cantly decreased, to 37.3 11.9% of control by phosphorylation of Ser408/409 ( p 0.05;
n 4). c, Phosphorylation of Ser408/409 residues in3-subunit enhances the binding of PP2A
in vitro. GST pulldown assays were performed as in b, and immunoblotting was done using
PP2Ac-specific antibody. The binding of PP2A to the intracellular loop of the 3-subunit was
potentiated by the phosphorylation of Ser408/409 (146 15% of control; p 0.05; n 4).
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dynamic mechanism likely to underlie functional plasticity of
these receptors at synaptic sites.
Discussion
GABAARs play a critical role in regulating neuronal activity and
are drug targets for a number of therapeutic agents, including
benzodiazepines and barbiturates (Whiting et al., 1999; Moss and
Smart, 2001). Moreover, modifications in GABAAR function are
implicated in epilepsy, anxiety disorders, and chronic substance
abuse (Whiting et al., 1999; Moss and Smart, 2001). Therefore, it
is of fundamental importance to understand the endogenous
mechanisms neurons use to regulate their function. In the
present study we have established that BDNF can bidirectionally
modulate the function of GABAA receptors and suggest a molec-
ular basis for this functional cross talk between BDNF/TrkB sig-
naling and GABAARs. Our results indicate that BDNF exerts its
regulatory influences at the level of two postsynaptic-specific
mechanisms: dynamic and prominent changes in the phosphor-
ylation of GABAAR receptors that affect receptor function, and
moderate stabilization of GABAAR at the neuronal plasma mem-
brane, both representing critical determinants of the strength of
inhibitory synaptic inputs. Although changes in the phosphory-
lation state of GABAARs correlate temporally with changes in
GABAAR-mediated synaptic currents, and are mediated by the
activity of the same signaling molecules, changes in the cell-
surface expression of GABAAR are unlikely to contribute to this
short-term and biphasic regulation of GABAARs by BDNF, and
may be involved in rather long-term effects of BDNF on inhibi-
tory synapses, for example, synapse formation and stabilization
(Rico et al., 2002).
It is evident that GABAARs are phosphorylated in neurons
under basal conditions (Brandon et al., 2000), but our studies
have illustrated that receptor phosphorylation is subject to dy-
namic modulation over both short and long durations. Impor-
tantly, we were able to establish that changes in the activity of
synaptic GABAARs after treatment with BDNF are paralleled by
alterations in the receptor phosphorylation state. Moreover, us-
ing a phosphorylation state-specific antibody we were able to
demonstrate that the BDNF-regulated phosphorylation of S408/
S409 in the 3-subunit was dependent on the activation of PKC
and occurred in a time frame concurrent with the potentiation of
receptor function. These residues are critical for the phospho-
dependent modulation of recombinant GABAARs by a number
of protein kinases (Krishek et al., 1994; Lin et al., 1996; Brandon
et al., 2000); therefore, our results strongly suggest that phos-
phorylation plays a critical role in regulating the activity of syn-
aptic GABAARs. Interestingly, although phosphorylation of 3-
subunit was robust in cortical neurons, 2- and 2-subunits did
not appear to be phosphorylated, despite the intracellular do-
mains of these subunits being PKC substrates in vitro (Brandon et
al., 2002a,b). These results may simply reflect the accepted differ-
ences between in vitro and in situ observations, or may suggest
that additional, as yet unidentified factors control the phosphor-
ylation of 2- and 2-subunits in cortical neurons.
Analyses of the rise and decay times for the mIPSCs indicated
that receptor phosphorylation and dephosphorylation are un-
likely to affect many aspects of the kinetic behavior of these chan-
nels. However, the BDNF-induced GABAA receptor phosphory-
lation may increase the mIPSC amplitudes by increasing: the
channel open probability (PO); the number of cell surface recep-
tors; the single channel current; or more subtly, receptor desensiti-
zation. Our biochemical evidence suggests that biphasic alterations
to the cell-surface receptor number are unlikely, but previous evi-
dence suggests that affecting synaptic receptor desensitization could
influence the mIPSC amplitudes (Jones and Westbrook, 1997), as
could modulation of channel PO (Moss et al., 1995).
Central to the regulation of GABAA receptors is the selective
targeting of signaling molecules to the receptor. Interestingly,
although the association of many other ion channels with various
signaling molecules has been demonstrated (Fraser and Scott,
1999; Levitan, 1999), the dynamics of these protein–protein in-
teractions remain unknown. Here we show that binding of PKC
to the GABAAR 3-subunit (localized to residues 395– 412 of this
subunit; Brandon et al., 1999), is reduced by the phosphorylation
of S408/S409. The GABAAR-1-subunit also undergoes
phospho-dependent binding of PKC (Brandon et al., 2002a,b). In
contrast, binding of PP2A was moderately enhanced by the phos-
phorylation of S408/S409 residues in the GABAAR-3-subunit.
Therefore, the relatively high affinity of PKC binding to dephos-
phorylated form of 3-subunit compared with its binding to the
phosphorylated form would be predicted to result in a transient
increase in phosphorylation of GABAA receptor, followed by de-
phosphorylation caused by the associated PP2A. In agreement
with this, BDNF treatment resulted in a transient enhancement
of GABAAR phosphorylation on the activation of PKC. Similar
transient phosphorylation of GABAAR--subunits is evident on
the activation of muscarinic acetylcholine receptors, which can
also signal to these receptors via the activation of PKC (Brandon
et al., 2002a,b). Therefore, phospho-dependent interaction of
PKC with receptor -subunits may be a common mechanism to
ensure the dynamic temporal modulation of GABAAR function
by PKC signaling pathways activated by both G-protein (Feng et
al., 2001) and neurotrophic factor receptors. PKC activity has
been shown to modulate GABAA receptor activity and cell-
surface stability at least in recombinant systems via both direct
and indirect mechanisms (Connolly et al., 1999; Brandon et al.,
2002a; Herring et al., 2003). Dissecting the relevance of these
differing mechanisms in neurons awaits the production of mice
in which the phosphorylation of individual GABAA receptor sub-
units has been abolished via homologous recombination.
BDNF is known to enhance the excitatory synaptic transmis-
sion, and its action is of importance for long-term potentiation in
the hippocampus (Poo, 2001). Our observations reveal that
BDNF reduces the efficacy of synaptic inhibition, which would be
predicted to further enhance neuronal excitation. Interestingly,
BDNF initially produces a transient enhancement of GABAAR func-
tion, the significance of which remains unknown. However, this
could be a short-term protective mechanism preventing an excessive
depolarization during conditions of high neuronal activity.
In conclusion, our results have revealed a novel role for BDNF
in controlling synaptic inhibition by modulating GABAAR phos-
phorylation and cell-surface stability. This regulation is likely to
be of importance in both the formation and functional matura-
tion of inhibitory synapses, given that BDNF/TrkB signaling
plays an essential role in synaptogenesis of GABAergic contacts.
In addition, the ability of BDNF to modulate GABAAR phos-
phorylation and activity, suggests a novel mechanism of action
for this neurotrophin in the control of neuronal excitability.
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